Vertical: CNMBase Year: 2025
Market Size (2025)
$22.44M
Projected (2032)
$33.33M
CAGR (2022–2032)
5.9%
Key Players
9+
Market Overview
The global N-(Phosphonomethyl)iminodiacetic Acid (PMIDA) market was valued at USD 22.439 Million in 2025 and is projected to reach USD 33.327 Million by 2032, expanding at a CAGR of 5.80% over 2026–2032. The market added USD 3.570 Million between 2022 and 2025 and is expected to add a further USD 10.888 Million between 2025 and 2032.
PMIDA (CAS No. 5994-61-6) is a phosphonate intermediate produced by the phosphonomethylation of iminodiacetic acid (IDA) with formaldehyde and phosphorous acid. Its principal commercial use is as the immediate precursor of glyphosate technical through oxidative cleavage, which makes the market a direct derivative of global glyphosate demand and of the share of glyphosate manufactured through the IDA route rather than the glycine route. A large share of global PMIDA output is consumed captively by integrated glyphosate producers; the market measured in this study reflects the value of PMIDA across the segmentation set out in Chapter 2.
Demand in the forecast period is supported by the continued use of glyphosate in herbicide-tolerant crop systems, conservation tillage and non-crop vegetation management; the build-out of large IDA-route PMIDA capacity in China; the expansion of glyphosate technical conversion in India and Southeast Asia; and a steady shift toward higher-purity PMIDA grades that improve catalytic oxidation yields and reduce effluent loads. These drivers are moderated by regulatory and litigation pressure on glyphosate in several jurisdictions, pronounced price cyclicality in the glyphosate chain and competition from glycine-route glyphosate.
Key Findings
By Downstream Product: Glyphosate is the largest segment, accounting for 95.0% of the market in 2025 (USD 21.317 Million). Others is the fastest-growing segment, with a CAGR of 7.40% over 2026–2032.
By Purity: 98% & Above is the largest segment, with a 2025 share of 75.0% (USD 16.829 Million), and is also the fastest-growing segment, at a CAGR of 6.49%. The Below 98% segment grows at 3.52%.
By Region: Asia Pacific is the leading region, accounting for 82.0% of the market in 2025 (USD 18.400 Million). Middle East & Africa is the fastest-growing region, with a CAGR of 7.78%.
By Country: China is the leading country, valued at USD 13.248 Million in 2025 (59.0% of the global market). Saudi Arabia is the fastest-growing country, with a CAGR of 8.48% over 2026–2032.
Segmentation Summary
The market is segmented by downstream product (Glyphosate and Others), by purity (98% & Above and Below 98%) and by region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa), with country-level analysis within each region. Glyphosate accounted for USD 21.317 Million in 2025 and is forecast to reach USD 31.474 Million by 2032, while the Others segment, which covers non-glyphosate uses of PMIDA, rises from USD 1.122 Million to USD 1.853 Million. By purity, the 98% & Above grade grows from USD 16.829 Million to USD 26.162 Million, lifting its share from 75.0% in 2025 to 78.5% in 2032.
Regionally, Asia Pacific is valued at USD 18.400 Million in 2025, reflecting the concentration of PMIDA and glyphosate manufacturing in China, which alone accounts for USD 13.248 Million. North America (USD 2.244 Million) is the second-largest region, followed by Latin America (USD 0.898 Million), Europe (USD 0.673 Million) and Middle East & Africa (USD 0.224 Million). Latin America and Middle East & Africa record the highest regional growth rates, at 7.07% and 7.78% respectively.
Competitive Landscape Summary
PMIDA supply is concentrated among a small number of integrated producers. Bayer AG, whose US glyphosate business was consolidated under its subsidiary Ruveon LLC in 2026, operates an integrated phosphorus-to-glyphosate chain in the United States based on the IDA route. In China, Sichuan Hebang Biotechnology is the leading merchant PMIDA producer and is constructing a 500,000 tonnes per year PMIDA project in Guang'an, while Nantong Jiangshan Agrochemical & Chemicals and Jiangsu Yangnong Chemical operate IDA-based glyphosate capacity. Large glyphosate producers that rely mainly on the glycine route, such as Hubei Xingfa Chemicals Group and Fuhua Tongda Chemical, compete with PMIDA-based supply in the downstream glyphosate market. Iminodiacetonitrile (IDAN) suppliers form a further layer of the competitive structure. Competition centres on raw-material integration, conversion cost, environmental compliance and access to export markets.
Challenges and Opportunities
The principal challenges are regulatory and litigation pressure on glyphosate, including the Roundup litigation in the United States and use restrictions in markets such as India; the steep cyclicality of glyphosate prices, which fell from above RMB 70,000 per tonne in 2022 to around RMB 24,000 per tonne by mid-2023; the cost of treating phosphorus-bearing effluent; and trade-policy uncertainty, illustrated by the anti-dumping and countervailing duty petitions on Chinese glyphosate and its intermediate filed and then withdrawn in the United States in mid-2026.
Opportunities arise from new IDA-route capacity designed around cleaner process technology, the relocation of glyphosate conversion closer to end markets (including Hebang's project in Indonesia), the growing preference for high-purity PMIDA in catalytic oxidation, and rising glyphosate consumption in Latin America, Africa and South Asia.
Future Outlook
The market is expected to grow steadily, from USD 23.762 Million in 2026 to USD 33.327 Million in 2032. Asia Pacific will remain the production and consumption centre of the market, while Latin America and Middle East & Africa will gain share on the back of agricultural expansion. Producers with integrated phosphorus and IDA feedstock, high-purity product capability and compliant effluent systems are best placed to capture this growth, and the outcome of regulatory reviews of glyphosate in the United States and elsewhere remains the main variable for the long-term demand trajectory.
The N-(Phosphonomethyl)iminodiacetic Acid Market market is projected to grow at a CAGR of 5.9% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
N-(Phosphonomethyl)iminodiacetic acid (PMIDA; CAS No. 5994-61-6; molecular formula C5H10NO7P; molecular weight approximately 227.1 g/mol), referred to as "diglyphosate" in Chinese trade usage, is an aminophosphonic acid in which a phosphonomethyl group is attached to the nitrogen atom of iminodiacetic acid. It is typically supplied as a white crystalline powder or as a moist filter cake and is sparingly soluble in water.
Commercially, PMIDA is manufactured by reacting iminodiacetic acid, or its sodium salt obtained from the hydrolysis of iminodiacetonitrile (IDAN) or the dehydrogenation of diethanolamine, with formaldehyde and phosphorous acid (generated from phosphorus trichloride) in a Mannich-type phosphonomethylation. PMIDA is then oxidised, using hydrogen peroxide or oxygen over activated-carbon or noble-metal catalysts, to N-(phosphonomethyl)glycine (glyphosate). This sequence is known as the IDA route to glyphosate, as distinct from the glycine route, which does not pass through PMIDA.
Included: PMIDA sold or transferred for the production of glyphosate technical and glyphosate salts, and PMIDA used for other applications (Others), such as other phosphonate derivatives and specialty chelating and chemical intermediate uses. Both high-purity (98% & Above) and lower-purity (Below 98%) grades are covered.
Excluded: Upstream raw materials (IDAN, IDA, diethanolamine, phosphorus trichloride, formaldehyde); glyphosate technical, glyphosate formulations and other downstream products; glyphosate produced through the glycine route; and unrelated phosphonates such as ATMP, HEDP and glyphosine (N,N-bis(phosphonomethyl)glycine).
Scope of the Study
Segmentation by Downstream Product: Glyphosate; Others.
Segmentation by Purity: 98% & Above; Below 98%.
Segmentation by Region: North America (U.S., Canada, Mexico); Europe (Germany, U.K., France, Italy, Spain, Rest of Europe); Asia Pacific (China, India, Japan, Rest of Asia Pacific); Latin America (Brazil, Argentina, Rest of Latin America); Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of MEA).
Timeline: Historic years 2022–2024; base year 2025; forecast period 2026–2032.
Currency: All values are presented in USD Million.
Research Objectives
To estimate the size of the global PMIDA market for 2022–2025 and forecast it for 2026–2032 in value terms (USD Million).
To analyse the market by downstream product and quantify the dependence of PMIDA demand on glyphosate production through the IDA route.
To assess the market by purity grade and the transition toward 98% & Above material for catalytic oxidation.
To analyse regional and country-level markets across North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
To identify the drivers, restraints, opportunities, trends and challenges that shape PMIDA demand, including glyphosate regulation, feedstock costs and capacity policy in China.
To evaluate the value chain, competitive forces, regulatory landscape and PESTEL environment specific to PMIDA.
To profile the competitive positioning of leading PMIDA, IDAN and IDA-route glyphosate producers and track key developments from 2022 onward.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured process combining secondary research, primary research, market modelling and validation. The research began with a definition of the product scope and segmentation, followed by the compilation of production, trade, capacity and pricing information along the phosphorus–IDA–PMIDA–glyphosate chain. Market estimates were built for each segment, region and country, validated through primary interviews, and then projected over 2026–2032 using a factor-based forecasting model. All estimates were reconciled so that segment, regional and country values sum to the global total in every year.
Secondary Research
Secondary research covered the following types of sources relevant to the PMIDA and glyphosate industry:
Industry associations: CropLife International and regional crop protection associations, the China Crop Protection Industry Association, the Pesticides Manufacturers & Formulators Association of India (PMFAI) and phosphorus-chemical industry bodies.
Government and regulatory bodies: the U.S. Environmental Protection Agency, the European Commission and European Food Safety Authority, the European Chemicals Agency, China's Institute for the Control of Agrochemicals under the Ministry of Agriculture and Rural Affairs, India's Central Insecticides Board & Registration Committee, Brazil's Ministry of Agriculture and Livestock, and national customs and trade statistics agencies.
Company filings: annual reports, interim reports, exchange announcements, investor presentations and environmental impact assessment disclosures of PMIDA, IDAN and glyphosate producers.
Trade journals and industry publications: agrochemical and fine-chemical trade press covering capacity changes, pricing and trade flows for glyphosate and its intermediates.
Patent and technical literature: patents and process literature on IDA, PMIDA and glyphosate synthesis and catalytic oxidation.
Paid databases: trade, company and pricing databases covering agrochemical intermediates and active ingredients.
Primary Research
Primary research was conducted through in-depth interviews with participants across the value chain to validate secondary findings, understand market dynamics and refine estimates. On the supply side, respondents included production, commercial and technical managers at PMIDA, IDAN and glyphosate technical manufacturers, as well as traders and distributors of agrochemical intermediates. On the demand side, respondents included procurement and technical managers at glyphosate technical and formulation companies and specialty chemical users of PMIDA. The objectives of primary research were to validate capacity, utilisation and pricing assumptions, confirm purity-grade usage patterns, assess regional demand and trade flows, and gather views on regulatory developments and future demand.
Market Size Estimation
Top-down approach: The global market was derived from glyphosate technical output, the share of glyphosate produced via the IDA route, PMIDA consumption per tonne of glyphosate, and PMIDA pricing, and was then allocated to downstream products, purity grades, regions and countries using production, consumption and trade data.
Bottom-up approach: Country-level estimates were built from the PMIDA and IDA-route glyphosate capacity, utilisation and trade of individual producers and from the glyphosate technical conversion activity of importing countries, and were aggregated to regional and global totals.
Data triangulation: Results from the two approaches were compared with each other and with primary-research inputs. Differences were reconciled by revisiting key assumptions on utilisation, conversion ratios and pricing until a consistent final estimate was reached.
Forecasting Methodology
Forecasts for 2026–2032 were developed using a factor-based model anchored on the 2025 base-year estimate. The factors considered included global glyphosate demand and crop-area trends, adoption of herbicide-tolerant crops, regulatory decisions on glyphosate, capacity additions and closures along the IDA route, competition from glycine-route glyphosate, phosphorus and other feedstock costs, price trends for PMIDA and glyphosate, and trade policy. Each factor was weighted for its expected impact over the short, medium and long term, and the resulting growth rates were applied to individual segments, regions and countries.
Base Year, Forecast Period and Currency
Base year: 2025
Historic years: 2022, 2023 and 2024
Forecast period: 2026–2032
Currency: USD Million
Assumptions and Limitations
Market values are expressed in nominal USD; currency conversions use average annual exchange rates for each year.
Captive consumption of PMIDA by integrated glyphosate producers is valued at prevailing merchant-market prices.
The forecast assumes no outright ban on glyphosate in a major agricultural market during 2026–2032.
The forecast assumes that announced capacity projects proceed broadly as disclosed by the companies concerned.
Limited public disclosure by unlisted Chinese producers and the volatility of glyphosate prices introduce uncertainty into the historic estimates and the forecasts.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The PMIDA market is moderately consolidated. A limited number of integrated producers control most IDA-route capacity, and a large share of PMIDA output is consumed captively in adjacent glyphosate units, so the merchant market is concentrated among a few suppliers. Global glyphosate capacity is estimated at about 1.2 million tonnes per year, of which China holds around 70%, with IDA-route capacity slightly larger than glycine-route capacity worldwide. In China, the IDA route is represented by producers such as Sichuan Hebang Biotechnology, Nantong Jiangshan Agrochemical & Chemicals and Jiangsu Yangnong Chemical, while the largest Chinese glyphosate producers, Hubei Xingfa Chemicals Group and Fuhua Tongda Chemical, rely mainly on the glycine route and compete with PMIDA-based supply in the downstream market. Outside China, Bayer AG operates the only integrated IDA-route chain in the United States.
Competition is based on raw-material integration (phosphate rock, yellow phosphorus, natural gas, IDA or IDAN), conversion cost, product purity and consistency, environmental compliance and access to export markets. Price competition is intense during downturns in the glyphosate cycle, and companies increasingly differentiate through vertical integration, by-product recycling, offshore conversion capacity and partnerships with multinational crop protection companies. Upstream IDAN producers, such as Chongqing Unisplendour Chemical and Guang'an Chengxin Chemical, influence the market by supplying non-integrated PMIDA manufacturers.
Key Player Positioning
Leaders
Bayer AG (Ruveon LLC): Bayer operates the integrated IDA-route glyphosate chain in the United States, with elemental phosphorus from Soda Springs, Idaho, and glyphosate production at Luling, Louisiana. The group reported sales of EUR 45.575 billion in FY2025, including EUR 21.622 billion from Crop Science. In July 2026, Bayer consolidated its US glyphosate business into Ruveon LLC to price competitively against generic supply while it pursues resolution of US litigation.
Sichuan Hebang Biotechnology Co., Ltd.: Hebang is the leading merchant PMIDA producer, with 200,000 tonnes per year of PMIDA and 60,000 tonnes per year of glyphosate capacity in 2025 based on a hydrocyanic-acid IDA route. It reported revenue of RMB 7.188 billion in FY2025, of which its PMIDA and glyphosate segment contributed RMB 2.513 billion. Its strategy combines the 500,000 tonnes per year Guang'an PMIDA project with a 350,000 tonnes per year glyphosate project in Indonesia.
Challengers
Nantong Jiangshan Agrochemical & Chemicals Co., Ltd.: Operates both IDAN-based and glycine-based glyphosate capacity, allowing it to switch to the cheaper route, and is expanding in Guizhou. It reported revenue of RMB 5.816 billion in FY2025.
Jiangsu Yangnong Chemical Co., Ltd.: A diversified active-ingredient producer controlled by Syngenta Group, with about 40,000 tonnes per year of glyphosate capacity based on an IDA route via diethanolamine. It reported revenue of RMB 11.870 billion in FY2025.
Zhejiang Xinan Chemical Industrial Group Co., Ltd. (Wynca): A major glyphosate and silicone producer with 80,000 tonnes per year of glyphosate technical capacity and the largest Chinese glyphosate exporter, with operations that include Zhenjiang Jiangnan Chemical. It reported revenue of RMB 14.625 billion in FY2025 and pursues a chlorine–phosphorus–silicon recycling model.
Hubei Xingfa Chemicals Group Co., Ltd.: China's largest glyphosate producer, with 230,000 tonnes per year of glyphosate technical capacity through Hubei Taisheng Chemical and Inner Mongolia Xingfa, mainly on the glycine route. It reported revenue of RMB 29.30 billion in FY2025 and competes with PMIDA-based glyphosate through its phosphorus integration and scale.
Fuhua Tongda Chemical Co., Ltd.: An unlisted Sichuan-based producer with around 150,000 tonnes per year of glycine-route glyphosate capacity. Its IPO prospectus reported revenue of RMB 9.529 billion for FY2022. It is extending into phosphorus flame retardants through a joint venture with Clariant.
Niche Players
Chongqing Unisplendour Chemical Co., Ltd.: An established Chinese producer of IDAN, a key feedstock for IDA-route PMIDA.
Guang'an Chengxin Chemical Co., Ltd.: A Sichuan-based IDAN producer supplying the PMIDA and glyphosate industry.
HPM Chemicals & Fertilizers Ltd.: An Indian agrochemical company that lists glyphosate technical made from PMIDA among its products, representing the import-and-convert model in India.
Threat of New Entrants – Low
New glyphosate capacity is a restricted category in China, and environmental approvals for phosphorus-bearing effluent are difficult to obtain.
Competitive PMIDA production requires large capital investment and integration with phosphorus and IDA/IDAN feedstock.
Incumbents benefit from scale, process know-how and established relationships with glyphosate converters.
Bargaining Power of Suppliers – Medium
Phosphorus, phosphorus trichloride and hydrocyanic acid are commodity inputs whose prices are influenced by energy costs and by restrictions on phosphate mining and yellow phosphorus output.
Large producers are backward integrated, which limits supplier leverage, but stand-alone producers depend on a small number of IDAN and phosphorus suppliers.
Bargaining Power of Buyers – Medium
Buyers are mainly glyphosate producers, many of which make PMIDA captively and can switch to the glycine route.
Merchant buyers in India and Southeast Asia have limited alternatives to Chinese supply, which moderates their bargaining power.
Buyer leverage rises in periods of glyphosate oversupply and falls when supply tightens.
Threat of Substitutes – Medium
The glycine route produces glyphosate without PMIDA and accounts for a large share of global capacity.
Alternative herbicides such as glufosinate, dicamba and 2,4-D can replace glyphosate in some weed-control programmes, particularly where resistance has developed.
No substitute currently offers glyphosate's combination of broad-spectrum activity and low cost, which limits substitution at scale.
Intensity of Competitive Rivalry – High
Global glyphosate capacity exceeds demand, and producers compete aggressively on price, especially during downturns.
Product differentiation is limited to purity, consistency and supply reliability.
Large Chinese producers compete for export markets with each other and with the integrated US producer.
Threat of New Entrants: Low; Capacity restrictions, environmental approvals, high capital needs.
Bargaining Power of Suppliers: Medium; Commodity inputs, offset by backward integration of leading producers.
Bargaining Power of Buyers: Medium; Captive production and route switching versus limited merchant alternatives.
Threat of Substitutes: Medium; Glycine route and alternative herbicides, but no equivalent at scale.
Intensity of Competitive Rivalry: High; Overcapacity, price-based competition, limited differentiation.
Market estimates by geography (2032)
InsightAsia Pacific leads with $27.42M by 2032, while Middle East & Africa is projected to grow fastest at a 7.9% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $1.93M | $2.48M | $3.15M | 5.0% | 9% |
| Europe | $0.58M | $0.74M | $0.93M | 4.8% | 3% |
| Asia Pacific | $15.45M | $20.65M | $27.42M | 5.9% | 82% |
| Latin America | $0.73M | $1.03M | $1.45M | 7.2% | 4% |
| Middle East & Africa | $0.18M | $0.26M | $0.38M | 7.9% | 1% |
| Total | $18.87M | $25.16M | $33.33M | 5.9% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$33.33M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Glyphosate | $31.47M | 5.8% | 94% |
| Others | $1.85M | 7.5% | 6% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on N-(Phosphonomethyl)iminodiacetic Acid Market covering market dynamics, competitive landscape, and strategic outlook.
The N-(Phosphonomethyl)iminodiacetic Acid Market market is projected to reach $33.33M by 2032, growing at 5.9% CAGR. The Glyphosate segment holds the largest share.
Demand for PMIDA is determined by the production of glyphosate through the IDA route, which in turn depends on herbicide demand in agriculture and non-crop vegetation management, on the relative economics of the IDA and glycine routes, and on regulation of glyphosate and of chemical manufacturing. This chapter sets out the factors that will shape the market over 2026–2032. The growth factor analysis in Section 4.2 rates five macro and five micro factors by type of impact and by an impact score out of 10 for three forecast windows; these scores are analyst assessments based on secondary research and primary interviews, where a higher score denotes a stronger influence on the market.
Sustained Global Demand for Glyphosate in Herbicide-Tolerant Crop Systems
Glyphosate remains the most widely used herbicide active ingredient in the world, and every tonne produced through the IDA route requires PMIDA as its immediate precursor. Its use is anchored in herbicide-tolerant soybean, corn, cotton and canola systems in the Americas, in no-till and minimum-tillage farming that replaces mechanical weed control with burndown applications, and in plantation, orchard and non-crop vegetation management. Adoption continues to widen. In January 2026, China's Ministry of Agriculture and Rural Affairs granted a biosafety certificate for production application to a glyphosate-tolerant genetically modified corn variety developed by the Chinese Academy of Agricultural Sciences, adding a potential new source of domestic demand in the world's largest glyphosate-producing country. In Brazil and Argentina, expansion of soybean and corn area sustains high glyphosate import volumes, with China supplying the large majority of Brazil's imports. Because glyphosate has no single substitute with comparable breadth of weed control and cost, demand for its intermediate tracks the long-term growth of global crop protection rather than short-term price swings, which underpins the steady growth of the Glyphosate downstream segment.
Expansion of IDA-Route PMIDA Capacity in China
Chinese producers are investing in large, integrated IDA-route capacity that will raise PMIDA output over the forecast period. Sichuan Hebang Biotechnology announced a 500,000 tonnes per year PMIDA project in Guang'an, Sichuan, in April 2022, designed around hydrocyanic-acid-based IDA from natural gas and in-house phosphorus. The company revised the investment to about RMB 7.0 billion in April 2026 and by July 2026 had signed procurement and construction contracts worth more than RMB 3 billion for the project, which is scheduled for completion in 2027. Nantong Jiangshan Agrochemical & Chemicals, which operates both IDAN-based and glycine-based glyphosate lines, completed the first 50,000 tonnes per year phase of its Guizhou glyphosate project at the end of 2025. These projects are located near phosphorus and natural-gas resources, which lowers feedstock cost and supports the competitiveness of the IDA route relative to the glycine route. As new capacity starts up, merchant PMIDA availability is expected to rise, supporting both domestic conversion and exports to glyphosate producers in other countries.
Growth of Glyphosate Technical Conversion in India and Southeast Asia
India is one of the fastest-growing PMIDA markets, with a CAGR of 7.52% over 2026–2032. Indian manufacturers produce glyphosate technical from imported PMIDA, a step that adds domestic value while relying on Chinese intermediate supply. Policy supports this model: the pesticide industry, through the Pesticides Manufacturers & Formulators Association of India, has pressed for mandatory registration of technical-grade pesticides and for limits on imports of finished technical products, measures intended to favour domestic manufacturing over the import of ready-made active ingredients. Producers such as HPM Chemicals & Fertilizers list glyphosate technical made from PMIDA among their products. In Southeast Asia, Hebang's joint venture with AKR Corporindo at the JIIPE industrial estate in East Java, Indonesia, announced in September 2023, includes glyphosate capacity that will be fed by PMIDA from China. The relocation of the oxidation step closer to consuming markets creates new cross-border demand for PMIDA.
Supply-Security Policies in Major Consuming Markets
Governments increasingly treat glyphosate and its raw materials as strategic agricultural inputs. In the United States, an executive order signed in February 2026 invoked the Defense Production Act in support of domestic production of glyphosate and elemental phosphorus, recognising that the country's only integrated producer, now Bayer's subsidiary Ruveon LLC, depends on phosphorus from Soda Springs, Idaho, and on IDA-route conversion at Luling, Louisiana. Supply disruptions such as the shutdown of the Luling plant after Hurricane Ida in 2021, and the price spike of 2021–2022, demonstrated the vulnerability of farmers to concentrated supply. Such policies favour the continuity of integrated PMIDA-based production in North America and encourage diversified sourcing elsewhere, supporting stable demand for the intermediate.
High-Purity PMIDA for Catalytic Oxidation
The 98% & Above segment is projected to grow at 6.49%, compared with 3.52% for the Below 98% segment. High-purity PMIDA improves the selectivity of catalytic oxidation to glyphosate, extends catalyst life and reduces impurities that must be removed from mother liquor. Producers able to supply consistent high-purity grades are positioned to win long-term contracts with glyphosate converters, especially those outside China that need to meet international specifications such as the FAO specification for glyphosate technical.
Offshore Conversion Hubs and New Trade Corridors
The move by Chinese producers to build glyphosate conversion capacity abroad, such as Hebang's planned 350,000 tonnes per year glyphosate project in Indonesia, together with technical manufacturing programmes in India, creates new demand for traded PMIDA. Exporting the intermediate rather than the finished active ingredient can also help producers manage trade-remedy risk in markets that scrutinise imports of finished glyphosate.
Demand Growth in Latin America and Africa
Latin America (CAGR 7.07%) and Middle East & Africa (CAGR 7.78%) are the fastest-growing regions. Expanding soybean and corn area in Brazil and Argentina, the spread of conservation agriculture in Southern Africa, and plantation agriculture across Africa support rising glyphosate use and offer opportunities for suppliers that can establish local formulation and conversion partnerships.
Regulatory and Litigation Pressure on Glyphosate
Glyphosate is subject to extensive regulatory review and litigation, which creates uncertainty for demand for its intermediates. In the United States, thousands of personal-injury claims have led Bayer to set aside large provisions; in February 2026, Monsanto proposed a class settlement of up to USD 7.25 billion, and in June 2026 the U.S. Supreme Court ruled in Monsanto's favour on federal preemption of state failure-to-warn claims. In India, the government restricted the use of glyphosate to pest control operators in October 2022. The European Union renewed glyphosate for ten years in November 2023, but with conditions on use, and several member states and municipalities continue to limit non-agricultural uses. Each of these measures can constrain glyphosate volumes and, therefore, PMIDA demand.
Price Volatility in the Glyphosate Chain
PMIDA prices move with glyphosate prices, which are highly cyclical. Chinese glyphosate technical prices rose to about RMB 80,000 per tonne at the end of 2021, remained above RMB 70,000 per tonne for part of 2022 and then fell to around RMB 24,000 per tonne by mid-2023 as supply recovered and channel inventories were drawn down. Such swings compress producer margins: Hebang reported a net loss in 2025, its first since listing, with a gross margin of 7.14% in its PMIDA and glyphosate segment. Volatility discourages investment by smaller producers and complicates contract pricing for buyers.
Environmental Compliance Costs
PMIDA and glyphosate manufacture generates phosphorus-bearing mother liquor, salt-laden wastewater and formaldehyde-containing by-products. Producers in China face strict inspection of effluent treatment, and new glyphosate capacity is classified as a restricted category under the country's industrial structure guidance. Investments in mother-liquor recovery, incineration and phosphorus recycling raise capital and operating costs and have historically forced the closure of non-compliant plants.
Consolidation and Vertical Integration
Leading producers are integrating backward into phosphate rock, yellow phosphorus, IDA or IDAN and phosphorus trichloride, and forward into glyphosate formulations. Integration reduces exposure to feedstock price swings and helps producers meet environmental requirements by recycling by-products. The trend favours large groups and raises barriers for stand-alone PMIDA producers.
Competition Between the IDA and Glycine Routes
Globally, IDA-route and glycine-route capacities are of similar scale, with China relying more heavily on the glycine route. The relative cost of the two routes depends on natural gas and hydrocyanic acid prices, glycine and chloroacetic acid prices and by-product credits. Some producers, such as Nantong Jiangshan, operate both routes and can shift output toward the cheaper one, which links PMIDA demand to inter-route economics.
Trade Remedies and Supply-Chain Scrutiny
On 30 June 2026, Ruveon LLC and Monsanto filed anti-dumping and countervailing duty petitions in the United States against glyphosate from China, with a scope that expressly covered the glyphosate intermediate PMIDA (CAS No. 5994-61-6). The petitions were withdrawn on 17 July 2026 following objections from farm groups, and the investigations were terminated. The episode shows that PMIDA can be drawn into trade actions on glyphosate and that importers may need to diversify their sources.
Tighter Product Regulation in China
China's "One Certificate, One Product, One Standard" pesticide management requirement took effect on 1 January 2026, tightening the link between registrations, products and quality standards. Together with ongoing environmental inspections and efforts to curb disorderly price competition in agrochemicals, the measure is expected to favour compliant, large-scale producers of glyphosate and its intermediates.
The PMIDA value chain links phosphorus and nitrogen chemistry with crop protection. Its principal stages are described below.
Raw materials and inputs: Phosphate rock is converted into yellow phosphorus and then phosphorus trichloride, which is hydrolysed to phosphorous acid. Natural gas or methanol is used to make hydrocyanic acid and formaldehyde, which are combined to produce IDAN; IDAN is hydrolysed to IDA, while diethanolamine dehydrogenation is an alternative route to IDA. Hydrochloric acid, caustic soda and catalysts are also required. Access to low-cost phosphorus and natural gas is the main source of cost advantage.
PMIDA manufacturing: IDA or its sodium salt is phosphonomethylated with formaldehyde and phosphorous acid under acidic conditions. The product is crystallised, filtered and washed to the required purity, and the mother liquor is treated or recycled. Plants are frequently integrated with IDAN and glyphosate units on the same site.
Conversion to glyphosate and other derivatives: PMIDA is oxidised to glyphosate acid using hydrogen peroxide or oxygen over activated-carbon or platinum-on-carbon catalysts. Glyphosate acid is then converted into salts (isopropylamine, potassium, ammonium) and formulated. A smaller volume of PMIDA is used in other phosphonate and specialty chemical applications.
Distribution and channels: Merchant PMIDA is sold directly by producers under term contracts or through chemical traders, mainly from China to glyphosate converters in India, Southeast Asia and other regions. Glyphosate technical and formulations move through agrochemical companies, distributors and retailers.
End users: Glyphosate-based herbicides are used by row-crop farmers, plantation and orchard growers, and non-crop users such as infrastructure, forestry and industrial vegetation managers, where permitted. Specialty chemical users consume PMIDA in other applications.
North America
United States: Glyphosate is registered under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) and is subject to registration review by the U.S. Environmental Protection Agency, which withdrew its glyphosate interim registration review decision in September 2022 and is re-evaluating the substance. Manufacture and import of chemical substances such as PMIDA fall under the Toxic Substances Control Act (TSCA).
Canada: Pesticides are regulated by Health Canada's Pest Management Regulatory Agency under the Pest Control Products Act; the agency confirmed the continued registration of glyphosate products following its 2017 re-evaluation.
Mexico: Pesticide registration and import are overseen by COFEPRIS together with agricultural and environmental authorities. A February 2023 decree set a phase-out of glyphosate, but in March 2024 the government postponed the prohibition, citing the lack of viable alternatives for agriculture.
Europe
European Union: Glyphosate approval was renewed until 15 December 2033 under Commission Implementing Regulation (EU) 2023/2660, subject to conditions of use, under the plant protection products framework of Regulation (EC) No 1107/2009. Chemicals manufactured in or imported into the EU, including intermediates, are subject to REACH (Regulation (EC) No 1907/2006) and to CLP classification and labelling (Regulation (EC) No 1272/2008).
United Kingdom: Plant protection products are regulated by the Health and Safety Executive under retained and domestic legislation, and chemicals under UK REACH.
Asia Pacific
China: The Regulations on Pesticide Administration govern registration, production licensing and quality of pesticides, administered by the Ministry of Agriculture and Rural Affairs through the Institute for the Control of Agrochemicals. The "One Certificate, One Product, One Standard" requirement took effect on 1 January 2026. Environmental protection laws and the industrial structure guidance catalogue govern effluent standards and new capacity.
India: Pesticides are regulated under the Insecticides Act, 1968, through the Central Insecticides Board & Registration Committee. In October 2022, the government restricted glyphosate use to pest control operators.
Japan: Agricultural chemicals are registered under the Agricultural Chemicals Regulation Act, and industrial chemicals are controlled under the Chemical Substances Control Law.
Latin America
Brazil: Law No. 14,785 of December 2023 established a new framework for the registration and control of pesticides, involving the Ministry of Agriculture and Livestock, ANVISA and IBAMA.
Argentina: Plant protection products are registered by the National Agri-Food Health and Quality Service (SENASA).
Middle East & Africa
South Africa: Agricultural remedies are registered under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act No. 36 of 1947).
Gulf Cooperation Council: Saudi Arabia and the UAE regulate pesticide registration through their national ministries responsible for environment and agriculture.
Jan 2022: Nantong Jiangshan Agrochemical & Chemicals; Restructuring; Ended its entrusted management of the glyphosate assets of Fuhua Tongda in Leshan, Sichuan.
Jan 2022: Hubei Xingfa Chemicals Group; Expansion; Subsidiary Inner Mongolia Xingfa planned 50,000 tonnes of new glyphosate capacity for 2022.
Apr 2022: Sichuan Hebang Biotechnology; Expansion; Announced a 500,000 tonnes per year PMIDA project in Guang'an, Sichuan, to expand on its existing PMIDA capacity.
Oct 2022: Nantong Jiangshan Agrochemical & Chemicals; Partnership; Agreed with Wengfu Group to develop a phosphorus-chemical park in Weng'an, Guizhou, including glyphosate capacity led by Jiangshan.
Jun 2023: Fuhua Tongda Chemical; Corporate; Filed for an initial public offering on the Shenzhen Stock Exchange main board.
Sep 2023: Sichuan Hebang Biotechnology; Partnership / Expansion; Announced a USD 800 million joint venture with AKR Corporindo at JIIPE, East Java, Indonesia, including glyphosate capacity.
H1 2025: Hubei Xingfa Chemicals Group; Product / Certification; FAO published specification 284/TC for glyphosate technical produced by subsidiary Hubei Taisheng Chemical.
Nov 2025: Fuhua Tongda Chemical; Partnership; Signed a joint venture agreement with Clariant for phosphorus flame retardants; construction began in May 2026.
Dec 2025: Nantong Jiangshan Agrochemical & Chemicals; Expansion; Completed the first 50,000 tonnes per year phase of its Guizhou glyphosate project, which entered trial production.
Feb 2026: Bayer AG (Monsanto); Legal; Monsanto proposed a US class settlement of up to USD 7.25 billion to resolve Roundup litigation.
Apr 2026: Sichuan Hebang Biotechnology; Expansion; Revised the planned investment in the Guang'an PMIDA project to about RMB 7.0 billion.
Apr 2026: Hubei Xingfa Chemicals Group; Expansion; Inner Mongolia Xingfa received approval for a sodium pyrophosphate unit and incineration of phosphorus-containing wastewater from its glyphosate plant.
Jun 2026: Bayer AG (Ruveon LLC / Monsanto); Trade Action; Filed US anti-dumping and countervailing duty petitions on glyphosate from China, with a scope covering the intermediate PMIDA; the petitions were withdrawn in July 2026.
Jul 2026: Bayer AG; Restructuring; Consolidated its US glyphosate business under the subsidiary Ruveon LLC.
Jul 2026: Sichuan Hebang Biotechnology; Expansion; Signed contracts worth RMB 3.054 billion for the 500,000 tonnes per year Guang'an PMIDA project and RMB 663 million for its 350,000 tonnes per year glyphosate project; Guang'an construction is scheduled to finish in October 2027.
Political
Supply-security policies, such as the 2026 US executive order on glyphosate and elemental phosphorus, support domestic integrated production.
Trade actions on Chinese glyphosate and its intermediates create sourcing uncertainty for importers.
China's industrial policy limits new glyphosate capacity and favours large compliant producers.
Economic
Glyphosate and PMIDA prices are highly cyclical and closely linked to farm incomes and crop prices.
Energy, phosphorus and natural gas costs determine production economics and route competitiveness.
Currency movements affect the competitiveness of Chinese exports.
Social
Public concern about glyphosate safety influences retailer policies, municipal restrictions and litigation.
Rural labour shortages encourage herbicide-based weed control instead of manual weeding.
Technological
Advances in oxidation catalysts and process control improve yields and enable high-purity PMIDA.
Mother-liquor recovery and phosphorus recycling technologies reduce effluent and raw-material consumption.
The spread of herbicide-tolerant traits, including new approvals in China, broadens glyphosate use.
Environmental
Phosphorus-bearing effluent and solid waste require costly treatment and are closely inspected.
Weed resistance to glyphosate is encouraging mixed-mode-of-action programmes that may moderate glyphosate volumes.
Conservation tillage enabled by glyphosate supports soil conservation and lower fuel use.
Legal
Product-liability litigation in the United States affects the strategy of the leading integrated producer.
Registration renewals, such as the 2023 EU renewal, and periodic reviews determine market access.
Chemical control laws, including REACH and TSCA, impose data and compliance obligations on intermediate producers and importers.
Profiles of 103 companies operating in the N-(Phosphonomethyl)iminodiacetic Acid Market market, including revenue, employee count, and market positioning where available.
Showing 103 of 103 companies
Bayer is a German life-science group with three businesses: Crop Science, Pharmaceuticals and Consumer Health. It is the world's largest combined seed, trait and crop-protection supplier, a mid-sized prescription-drug maker, and a top-five self-care company. Fiscal 2025 sales were EUR 45.6 billion. The 2018 purchase of Monsanto brought leading corn and soybean genetics but also glyphosate and PCB litigation, which has consumed well over EUR 10 billion in settlements and produced net losses in 2023, 2024 and 2025. Under CEO Bill Anderson the company has cut management layers, held the dividend at the legal minimum, and concentrated on four priorities: rebuilding the pharma pipeline, containing litigation, reducing debt and improving crop profitability. In 2026 a 7–2 U.S. Supreme Court ruling on federal pre-emption and a proposed USD 7.25 billion class settlement moved the litigation closer to resolution, though the settlement still awaits final court approval. --- **Company's own description.** Bayer describes itself as a global enterprise with core competencies in the life-science fields of health care and nutrition, operating under the mission "Health for all, Hunger for none" (Annual Report 2025; press boilerplate 2026). Bayer AG is a holding company; operations sit in subsidiaries worldwide. In fiscal 2025 the Group had about 88,000 employees, sales of EUR 45.6 billion and R&D expenses of EUR 5.8 billion. **Independent characterisation.** Bayer is best understood as three distinct businesses sharing a balance sheet, a brand and a legal liability. Crop Science (47 percent of FY2025 sales) is an input supplier to farmers. It earns money from proprietary seed and biotech traits, from chemical and biological crop protection, and to a small extent from digital farming subscriptions. Seed and trait revenue carries royalty-like economics: Bayer licenses traits to other seed companies, and two licensing settlements with Corteva lifted results in Q4 2025 and Q1 2026. The business is strongly seasonal, with Northern Hemisphere sales concentrated in the first half and Latin American sales in the second. Pharmaceuticals (39 percent of sales) discovers, develops and sells prescription medicines, concentrated in cardiovascular and renal disease, oncology, women's health and ophthalmology, plus a radiology unit selling contrast agents and injector hardware. Revenue is almost entirely product sales, with some licence income (for example U.S. Xarelto royalties from Johnson & Johnson, and Eylea outside the United States under a collaboration with Regeneron). The division is in the middle of a patent transition: Xarelto and Eylea are declining while Nubeqa and Kerendia are growing quickly. Consumer Health (13 percent of sales) sells non-prescription brands through pharmacies, mass retail and e-commerce. It is a branded consumer-goods model with stable margins and low capital intensity. **Revenue model mix.** Bayer does not disclose a product/service/licensing split. On the evidence of the Annual Report 2025, the large majority of revenue is product sales; licensing income is embedded in Crop Science seed and trait lines and in Pharmaceuticals; subscription revenue (Climate FieldView, radiology software) is immaterial at Group level. An exact percentage split is not publicly disclosed. **Value-chain position.** Bayer is a research-based originator and manufacturer. It owns discovery, development, active-ingredient and finished-product manufacturing, and commercial organisations, and sells through distributors, retailers, wholesalers, hospitals and pharmacies rather than directly to end users in most markets. **Customers and end markets.** Farmers, agricultural retailers and distributors, and seed licensees (Crop Science); wholesalers, hospitals, physicians, pharmacy chains, governments and payers (Pharmaceuticals); pharmacies, supermarkets, drugstores and online retailers (Consumer Health).
DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).
Nippon Soda is a mid-cap, diversified Japanese chemical group founded in 1920 as a chlor-alkali producer and progressively re-shaped into a portfolio anchored by two high-value franchises: research-based crop protection (Agri Business, 35% of FY3/26 sales) and specialty "Chemical Materials" (25%), complemented by lower-margin but stable trading/logistics, plant engineering and environmental-recycling businesses. Its crown jewels are niche, high-barrier products in which it holds globally relevant positions — the pharmaceutical excipient NISSO HPC (hydroxypropyl cellulose), liquid polybutadiene NISSO-PB for AI-server copper-clad laminates, KrF photoresist polymer VP-POLYMER, and proprietary agrochemicals such as Mospilan (acetamiprid) and Topsin-M. With FY3/26 net sales of JPY 152.1 billion, record net profit of JPY 18.3 billion, an equity ratio of ~66.6%, and a 50%+ total shareholder return policy, the company is a conservatively financed, R&D-led specialty player now pivoting toward healthcare (including animal health) and advanced ICT materials under its Stage III plan to FY3/30. --- ### Company's own description According to its Stage III medium-term plan (May 2026), Nippon Soda describes its mission as creating new value through the power of chemistry, and frames the group as supporting everyday life through chemical products and services across four "material" fields: Agriculture (securing food and sustainable agriculture), Healthcare (healthy life for all people), Environment (toward a resource-recycling society) and ICT (chemical functions for IT devices). The Yuho describes the parent's business as manufacturing, processing and marketing of industrial chemicals, synthetic resins and plastics, dyes, pharmaceuticals, agrochemicals, veterinary pharmaceuticals and other chemical products. ### Business model and revenue model Nippon Soda's revenue is overwhelmingly product-based (manufactured chemical sales), with secondary service revenues from logistics (warehousing, transport, customs brokerage), engineering/EPC contracts and waste treatment. There is no material subscription revenue. Licensing/active-ingredient supply is embedded in Agri Business: the company supplies proprietary active ingredients (AIs) to global majors and sells formulated products through its own overseas network and partners. The revenue mix by nature (approximation from FY3/26 segment data; company does not disclose a product/service split): *Note: the above split is an analytical characterization; the company does not report revenue by nature.* ### Value-chain position **Agri Business:** fully integrated R&D-type agrochemical originator — chemical synthesis, biological/safety research, formulation research, field evaluation, AI manufacturing (including via Nisso Namhae Agro in Korea) and formulation, registration and global marketing (Stage III plan). The company emphasizes that R&D-type agrochemical originators are largely limited to five overseas majors plus Japanese firms, and that Japanese originators punch above their weight in new AI discovery. **Chemical Materials:** upstream chlor-alkali (caustic soda, chlorine, hydrochloric acid) feeding downstream fine/specialty chemistry (living anionic polymerization for NISSO-PB and VP-POLYMER; cellulose derivatization for HPC; penem API synthesis). **Trading & Logistics:** captive and third-party distribution (Nisso Shoji) and specialized hazardous/pharma logistics (Sanwa Soko, Sanso Unyu). **Engineering:** fine-chemical-type EPC (Nisso Engineering) and civil works (Nisso Kensetsu). **Eco Solutions:** waste treatment, zinc recovery from electric-arc-furnace dust, sulfuric acid recycling (Nisso Metallochemical). ### Customer types and end-markets Customers include global agrochemical majors and distributors, farmers' cooperatives (via channels), generic and innovator pharmaceutical companies and supplement makers (HPC, SSF, faropenem API), copper-clad-laminate (CCL) and semiconductor-materials producers (NISSO-PB, 1,2-SBS, VP-POLYMER), thermal-paper manufacturers (color developers), battery-materials producers, industrial users of commodity chemicals, steelmakers (EAF dust treatment), and public/private construction clients (Engineering). End-markets: crop protection (fruit & vegetables first, expanding to grains), pharmaceuticals/nutraceuticals, semiconductors/electronics (AI servers, HBM, automotive chips), infrastructure, and environmental services. ### Independent characterization Nippon Soda is best understood as two engines and three stabilizers. The engines — Agri Business and specialty Chemical Materials — generated roughly 75% of FY3/26 segment operating profit (JPY 11.2 billion of JPY 14.97 billion before adjustments) on 60% of sales. Agri is cyclical and FX-sensitive (65.7% overseas sales ratio in FY3/26), while Chemical Materials has been structurally re-rated from a ~5–6% margin business to ~15–17% after exiting commodity lines (metallic sodium via Alkaline S.A.S., NISSO HI-CHLON, phenol-based color developers, sodium cyanide). The stabilizers (Trading & Logistics, Engineering, Eco Solutions) are low-growth and modest-margin but add scale and cash. A further, often-overlooked profit pillar is equity-method income (JPY 6.06 billion in FY3/26, chiefly Iharabras in Brazil), which made ordinary profit (JPY 22.99 billion) much larger than operating profit and is highly FX-sensitive (BRL/USD).
RPM International is a holding company for more than a dozen semi-autonomous specialty-chemicals franchises. These businesses make coatings, sealants, roofing, concrete admixtures, flooring, fireproofing and building-envelope systems, mostly for maintenance, repair and restoration rather than new construction. Its brand portfolio is unusually deep for a USD 7.9 billion company: Rust-Oleum, DAP, Zinsser, Varathane and The Pink Stuff on the consumer side; Tremco, Euclid, Dryvit, Nudura, Kalzip, Stonhard, Carboline and Fibergrate on the professional side. Each brand holds a leading position in a niche that larger diversified coatings groups do not dominate. Since 2018 RPM has run successive operational-improvement programs (MAP to Growth, MAP 2025, and now "MAP 3.0"). These have lifted gross margin from about 36% (FY2022) to about 41% (FY2026) and moved the group from a loose federation toward a centrally coordinated operating company. RPM is a disciplined, dividend-growing compounder with 52 consecutive annual dividend increases. Its growth vectors are engineered building systems, emerging markets (the "Platform" model) and bolt-on M&A. --- ### Company's own description (FY2026 Form 10-K, Item 1) RPM describes itself as follows: its subsidiaries manufacture, market and sell specialty chemical product lines, including high-quality specialty paints, infrastructure rehab and repair products, protective coatings, roofing systems, sealants and adhesives. These products focus on the maintenance and improvement needs of the construction, industrial, specialty and consumer markets. Footprint as of 31 May 2026: - Products marketed in about 167 countries and territories. - Manufacturing in about 120 locations across 22 countries. - About 31% of sales generated internationally: foreign operations 29.8% of net sales, plus direct U.S. exports of 0.9%. The press-release boilerplate calls RPM "a world leader in specialty coatings, sealants, building materials and related services." ### Business model RPM's model has four defining features. - **Decentralised entrepreneurial structure, becoming more integrated.** The founder's philosophy, still quoted in the 2026 proxy, is: "Hire the best people you can find. Create an atmosphere that will keep them. Then let them do their jobs." Operating companies historically kept their own brands, sales forces and ERP systems. The MAP programs are deliberately centralising procurement, manufacturing, accounting and IT. The stated goal is to consolidate more than 75 ERP systems to one platform per segment (Q4 FY2026 8-K). **Repair and maintenance bias:** Much of the portfolio serves existing assets: roof restoration, re-cover, concrete repair, corrosion control, rust prevention and DIY touch-up. That demand is less cyclical than new-build construction. The FY2026 10-K notes that re-roofing has historically accounted for over three-quarters of U.S. roofing demand. **Systems and turnkey selling:** In CPG and PCG, RPM increasingly sells integrated systems (the "Power of One" building envelope) and supply-and-apply turnkey services. Examples include Stonhard flooring installation and Weatherproofing Technologies roofing services. This captures more of each construction project's spend. **Bolt-on M&A plus organic growth:** RPM completed six acquisitions in each of FY2025 and FY2026 (FY2026 10-K Note F). ### Revenue model mix RPM does not disclose a product versus service versus licensing split. From filings, the mix is: ### Value-chain position RPM is a formulator and brand owner, positioned downstream of commodity chemical producers. It buys petroleum-derived resins, solvents, pigments, minerals, metals and packaging (FY2026 10-K, Raw Materials). It is selectively backward-integrated: RPM cites expanding in-house raw material production, and Arnette Polymers makes amine curing agents and epoxy intermediates. Channels downstream include: - Mass merchants and home centres, where the single largest Consumer customer was 20% of Consumer sales in FY2026. - Hardware and paint stores. - Distributors. - Contractors and specifiers. - Direct sales to industrial plant owners, public institutions and infrastructure agencies. ### Independent characterisation RPM is best understood as a portfolio of niche category leaders with a structural margin-improvement story layered on top. The professional segments (CPG and PCG) are about 66% of sales and supply the growth. In FY2026 they posted record results driven by high-performance buildings, data centres, infrastructure, fireproofing and concrete admixtures. In Q1 FY2027, emerging-market regions grew more than 20%. The Consumer segment is about 34% of sales. It is a cash-generative but volume-challenged DIY business. Organic Consumer sales fell 0.8% in Q4 FY2026 and 4.7% in Q2 FY2026. They recovered to +5.2% in Q1 FY2027 on shelf-space wins and pricing. The equity debate therefore centres on three questions: 1. Can MAP savings and pricing protect margins against renewed raw-material inflation linked to the Middle East conflict? 2. Is the Q1 FY2027 CPG slowdown temporary? 3. Will the 9 November 2026 investor day credibly frame the next margin plan?
3 interactive charts drawn from the N-(Phosphonomethyl)iminodiacetic Acid Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global N-(Phosphonomethyl)iminodiacetic Acid Market By Purity
Global N-(Phosphonomethyl)iminodiacetic Acid Market By Downstream Product
Global N-(Phosphonomethyl)iminodiacetic Acid Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
